Advertisement

Zusammenfassung

Cholera ist eine Erkrankung, die durch eine Infektion mit dem gramnegativen Bakterium Vibrio cholerae verursacht wird. Die Erkrankung wird charakterisiert durch eine sehr schwere, wässrige Diarrhö mit einer schnell einsetzenden Dehydratation, die bei mehr als 50% aller unbehandelten Patienten zum Tode führt. Eine Cholera sollte deshalb frühzeitig bei allen Patienten aus potenziellen Endemiegebieten mit schwerer wässriger Diarrhö und Erbrechen mit schnell einsetzender schwerer Dehydratation abgeklärt werden. Alle Patienten mit Verdacht auf Cholera müssen sofort, auch vor Sicherung der Diagnose, behandelt werden, da der Tod durch Dehydratation innerhalb von Stunden auftreten kann.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alam NH, Majumder RN, Fuchs GJ: Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: A randomised double-blind clinical trial. Lancet 345: 296 (1999)CrossRefGoogle Scholar
  2. Bart KJ, Huq Z, Khan M, Mosley WH: Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J Infect Dis 121(Suppl): 17 (1970)PubMedGoogle Scholar
  3. Butterton JR, Calderwood SB: Vibrio cholerae O1. In: Infections of the Gastrointestinal Tract, Blaser MJ, Smith PD, Ravdin JI et al. (eds), Raven Press, New York, p 649 (1995)Google Scholar
  4. Cash RA, Music SI, Liponati JP et al.: Response of man to infection with Vibrio cholerae. I. Clinical, serologic, bacteriologic responses to a known inoculum. J Infect Dis 129: 45 (1974)PubMedGoogle Scholar
  5. Gerichter CB, Sechter I, Cohen J, Davies AM: A serological survey for cholera antibodies in the population of Jerusalem and surroundings. Isr J Med Sci 9: 980 (1973)PubMedGoogle Scholar
  6. Gilman AG: Proteins and dual control of adenylate cyclase. Cell 36: 577 (1984)PubMedCrossRefGoogle Scholar
  7. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML et al.: DNA sequence of both chromosomes of the cholera pathogen Vibio cholerae. Nature 406: 477 (2000)PubMedCrossRefGoogle Scholar
  8. Holmgren J: Actions of cholera toxin and the prevention an treatment of cholera. Nature 292: 413 (1981)PubMedCrossRefGoogle Scholar
  9. Hornick RB, Music SI, Wenzel R et al.: The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bull N Y Acad Med 47: 1181 (1971)PubMedGoogle Scholar
  10. Lucas MES, Deen JL, von Seidlein L et al.: Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352: 757–767 (2005)PubMedCrossRefGoogle Scholar
  11. Morris, JG: Non-O group 1 Vibrio cholerae: at the epidemiology of an occasional pathogen. Epidemiol Rev 12: 179 (1990)PubMedGoogle Scholar
  12. Oseasohn R, Ahmad S Islam MA, Rahman ASSM: Clinical and bacteriological findings among families of cholera patients. Lance 1: 340 (1966)CrossRefGoogle Scholar
  13. Peterson JW, Ochoa LG: Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 245: 857 (1989)PubMedGoogle Scholar
  14. Rabbani GH, Greenough WB 3rd: Pathophysiology and clinical aspects of cholera. In: Cholera, Barua D, Greenough WBI (eds), Plenum Press, New York, p 209 (1992)Google Scholar
  15. Snow J: On the mode of communication of cholera. John Churchill, London (1849)Google Scholar
  16. Swerdlow DL, Mintz ED, Rodriguez M et al.: Waterborne transmission of epidemic cholera in Trujillo, Peru: Lessons for a continent at risk. Lancet 340: 28 (1992)PubMedCrossRefGoogle Scholar
  17. Wald A, Gotterer GS, Rajendra GR et al: Effect of indomethacin on cholera-induced fluid movement, unidirectional sodium fluxes, and intestinal cAMP. Gastroenterology 72: 106 (1977)PubMedGoogle Scholar
  18. Wang F, Butler T, Rabbani GH, Jones PK: The acidosis of cholera: Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med 315: 1591 (1986)PubMedCrossRefGoogle Scholar
  19. Woodward WE, Moseley WH: The spectrum of cholera in rural Bangladesh: II: Comparison of El Tor, Ogawa and classical Inaba infection. Am J Epidemiol 96: 342 (1972)PubMedGoogle Scholar
  20. World Health Organization: A manual for the treatment of diarrhea. Geneva: Programme for Control of Diarrheal Diseases. Publication WHO/CCD/SER/80.2 rev 2 (1990)Google Scholar
  21. Yamamoto T, Nair G, Albert MJ et al.: Survey of in vitro susceptibilities of Vibrio cholerae O1 and 0139 to antimicrobial agents. Antimicrob Agents Chemother 39: 241 (1995)PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2006

Authors and Affiliations

  • H. R. Brodt
    • 1
  1. 1.Medizinische Klinik III, Abt. Infektiologie, Klinikum der Johann WolfgangGoethe-UniversitätFrankfurt am Main

Personalised recommendations